ketotifen has been researched along with emedastine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, T; Iemura, R; Ito, K; Kawashima, T; Morimoto, Y; Tsukamoto, G | 1 |
Fukuda, T; Ito, K; Saito, T | 1 |
Inagaki, N; Kanke, T; Matsumoto, J; Nagai, H; Nagao, M; Takizawa, T; Timmerman, H; Tohma, T; Wada, Y; Zhang, MQ | 1 |
Bensch, G; D'Arienzo, PA; Leonardi, A | 1 |
Blondin, C; Cholley, B; Goldschmidt, P; Haeffner-Cavaillon, N | 1 |
Montero, JA; Pastor, S; Rodriguez, AE; Ruiz-Moreno, JM; Sanchis-Merino, ME | 1 |
Akman, A; Akova, YA; Borazan, M; Erbek, SS; Karalezli, A; Kiyici, H | 1 |
2 trial(s) available for ketotifen and emedastine
Article | Year |
---|---|
Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model.
Topics: Allergens; Anti-Allergic Agents; Benzimidazoles; Conjunctivitis; Double-Blind Method; Eye Color; Female; Humans; Hypersensitivity; Ketotifen; Male; Ophthalmic Solutions; Pruritus | 2002 |
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
Topics: Adolescent; Adult; Anti-Allergic Agents; Benzimidazoles; Child; Conjunctival Diseases; Conjunctivitis, Allergic; Dibenzazepines; Dibenzoxepins; Double-Blind Method; Edema; Eyelid Diseases; Female; Fluorometholone; Histamine H1 Antagonists; Humans; Imidazoles; Ketotifen; Male; Middle Aged; Olopatadine Hydrochloride; Ophthalmic Solutions; Prospective Studies; Pruritus; Seasons; Tears; Treatment Outcome; Young Adult | 2009 |
5 other study(ies) available for ketotifen and emedastine
Article | Year |
---|---|
Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators.
Topics: Acetylcholine; Airway Resistance; Animals; Benzimidazoles; Bradykinin; Capillary Permeability; Guinea Pigs; Histamine; Histamine H1 Antagonists; Ileum; In Vitro Techniques; Ketotifen; Muscle Contraction; Muscle, Smooth; Neurotransmitter Agents; Parasympatholytics; Serotonin Antagonists; Trachea | 1984 |
Antiasthmatic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413), a new antiallergic.
Topics: Airway Resistance; Anaphylaxis; Animals; Asthma; Benzimidazoles; Chlorpheniramine; Guinea Pigs; Histamine H1 Antagonists; Ketotifen; Male; Respiration; Time Factors | 1984 |
VUF-K-8788, a periphery-selective histamine H1 antagonist with anti-pruritic activities.
Topics: Animals; Anti-Allergic Agents; Behavior, Animal; Benzimidazoles; Capillary Permeability; Guinea Pigs; Histamine; Histamine H1 Antagonists; In Vitro Techniques; Ketotifen; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Muscle Contraction; Passive Cutaneous Anaphylaxis; Peripheral Nervous System; Piperazines; Pruritus; Pyrilamine; Rats; Rats, Wistar; Terfenadine; Thiazines | 2001 |
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
Topics: Air Pollutants; Anti-Allergic Agents; Benzalkonium Compounds; Benzimidazoles; Complement Activation; Conjunctivitis; Cosmetics; Dibenzoxepins; Dipeptides; Drug Evaluation; Dust; Humans; In Vitro Techniques; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Ophthalmic Solutions; Oxamic Acid; Phthalazines; Piperidines; Pollen; Silicon Dioxide; Zymosan | 2003 |
Comparative efficacy of topical antihistamines in an animal model of early phase allergic conjunctivitis.
Topics: Animals; Anti-Allergic Agents; Benzimidazoles; Coloring Agents; Conjunctivitis, Allergic; Dibenzoxepins; Dipeptides; Disease Models, Animal; Drug Evaluation, Preclinical; Evans Blue; Guinea Pigs; Histamine H1 Antagonists; Ketotifen; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Phthalazines; Severity of Illness Index; Treatment Outcome | 2008 |